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Abstracts 395neurologic events included 2 major and one minor stroke (11%). Transient
spinal cord ischemia with full recovery was observed in 2 patients (7%). One
myocardial infarction required medical treatment (4%) and 2 renal function
impairment (7%) were depicted. Early (<30 day) re-interventions (11%)
were performed to treat one access complication, one left ventricle false
aneurysm suspicion and one limb ischemia. During follow up (median 12
months), 1 patient (4%) died from a remote TAAA rupture. Two type 2 (7%)
and one type 3 endoleaks (4%) were depicted. During follow up, 2 (7%) re-
interventions were performed to treat the type 3 endoleak and a septic
aortic false aneurysm.
Conclusion: The outcomes associated with this new technique are
favourable when the procedure is performed in experienced centres.
Branched endografting of arch aneurysms should be considered in patients
unﬁt for open surgery.
Long-term Survival after TEVAR depends on Indication for
Surgery, and is Shorter than Expected after Ruptured Thoracic
Aneurysm
T. Hellgren, A. Wanhainen, M. Björck, K. Mani
Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University
Hospital, Sweden
Introduction: Thoracic endovascular aortic repair (TEVAR) is used in
treatment of type B aortic dissections and descending aortic aneurysms
increasingly often. TEVAR is associated with lower peri-operative mortality
when compared to open surgery in retrospective studies. We assessed
long-term survival after TEVAR depending on diagnosis.
Methods: All patients who underwent TEVAR for type B aortic dissec-
tion or thoracic aortic aneurysm at Uppsala University Hospital between
December 1999 and December 2013 were included. Traumatic aortic
transections, thoraco-abdominal- and mycotic aneurysms, as well as type A
dissections were not included. Patient characteristics and survival data
were collected from medical records. 30 day survival was analyzed with
chi2 and 5 year survival was estimated with Kaplan-Meier. Age-adjusted
survival was estimated with a Cox regression analysis.
Results: Of the 250 patients who underwent TEVAR, 190 were included
(excluded: traumatic transections n ¼ 17, thoraco-abdominal hybrid pro-
cedures n ¼ 20, mycotic aneurysms n ¼ 5, type A dissections n ¼ 8, others
n ¼ 10). Diagnosis distribution was acute type B aortic dissection (ABAD)
n¼ 63; chronic typeB aortic dissection (CBAD) n¼ 45; intact aneurysm (iTAA)
n ¼ 57 and ruptured aneurysm (rTAA) n ¼ 25. Mean follow up was 49
months. Mean age of the patients was ABAD 66.5 years; CBAD 61.9; iTAA
71.6; rTAA 74.5 (p< 0.001).The male to female ratio was ABAD 41:22; CBAD
34:11, iTAA 34:23, rTAA 12:13 (p¼ 0.132). 30 day survival was ABAD 92.1%;
CBAD 95.6%; iTAA 96.5%; rTAA 72.0% (p¼ 0.002). 5 year survival was ABAD
79.2%; CBAD 79.6%; iTAA 66.0%; no patient with 5 year follow up after rTAA
was alive, and 3 year survival was 30.8%, see attached ﬁgure (Log-Rank
p< 0.001). In a Cox regression analysis of mid-term survival for patients who
survived the initial 30 day peri-operative period, age-adjusted hazard ratio for
death was 5.7 after rTAA compared to the other diagnoses.
Conclusion: Long-term survival after TEVAR was adequate for patients
with type B aortic dissection and intact aortic aneurysm. Considering the
poor long-term survival after TEVAR for ruptured aortic aneurysm, it may
be necessary to be more selective when deciding which of these patients
who beneﬁt from active treatment.
Renal Dysfunction following Thoraco-abdominal Aortic Surgery:
Occurrence and Long-Tterm Mortality
C.C. Miller, III, H.K. Sandhu, K.M. Charlton-Ouw, A. Azizzadeh,
A.L. Estrera, H.J. Saﬁ
University of Texas Medical School at Houston, Houston, TX, USA
Introduction: Renal failure is a signiﬁcant source of morbidity and mortality
in patients who require thoraco-abdominal (TAA) aortic repair. We
reviewed our 25 year experience with open descending thoracic and
thoraco-abdominal repair to identify risk factors for and potential thera-
peutic targets to prevent renal failure.Methods: We performed 1896 operations in 1795 patients. The ma-
jority of cases were performed using cerebrospinal ﬂuid drainage and
distal aortic perfusion, and visceral perfusion was used selectively in
patients with repairs that involved the origins of the celiac, superior
mesenteric and renal arteries. Renal failure was deﬁned as new-onset
renal dysfunction in patients without existing chronic renal disease, and
included an increase in post-op creatinine >1 mg/dl/day over the ﬁrst
two post-op days, an absolute creatinine >4 mg/dl or need for dialysis.
Multivariable statistics were used to assess pre-and intra-operative risk
factors for renal dysfunction, and the effect of renal morbidity on long-
term survival was evaluated by Kaplan-Meier analysis.
Results: Mean population age was 64.2 +/- 13.9, and 669/1795 (37%)
patients were female. Renal dysfunction occurred after 488/1896 (25.7%)
operations. Multivariable pre-operative predictors of post-operative renal
failure were patient age (OR 1.03/yr, p < 0.0001), TAA extent 1 (OR 2.02,
p < 0.0001), TAA2 (OR 5.9, p < 0.0001), TAA3 (OR 4.2, p < 0.0001), TAA4
(OR 2.9, p < 0.0001), emergency presentation (OR 1.4, p < 0.04) and
coronary artery disease (CAD; OR 1.3, p < 0.04). Addition of intra-operative
variables identiﬁed patient age (OR 1.03/yr, p < 0.0001), aortic dissection
(OR 0.62, p < 0.002), involvement of the aortic segment containing the
visceral vessel origins (OR 1.5, p < 0.005), COPD (OR 1.3, p < 0.02), aortic
cross clamp time (OR1.02/min, p < 0.0001), and PRBC use (OR 1.04/unit,
p < 0.0001). Visceral perfusion was associated with modestly increased risk
(OR 1.3, p < 0.04) among patients with aneurysm extents (TAA 1, 2, and 4)
involving the visceral vessels. Incidence of renal dysfunction has risen
gradually over time. Long-term survival is strongly inﬂuenced by post-
operative renal failure (Figure, p < 0.0001).
Conclusion: New-onset renal dysfunction is common after thoraco-
abdominal aortic surgery, and is strongly associated with reduced long-
term survival. Renal protection strategies are urgently needed, and treat-
ments that can reduce the effects of ischemic time and transfusion are
likely intervention targets.
Acute Endovascular Repair of Ruptured Thoraco-abdominal
Aneurysms with Branched Stentgrafts
N. Dias, B. Sonesson, T. Kristmundsson, K. Björses, J. Holst, T. Resch
Vascular Center, Skåne University Hospital, Malmo, Sweden
Introduction: Endovascular repair of thoraco-abdominal aneurysms with
branched stent grafts (bEVAR) has shown promising results in the elec-
tive situation. Off the shelf devices have been introduced recently
allowing endovascular treatment of TAAA in the acute setting, including
rupture (rTAAA). However, very little is known about acute bEVAR for the
treatment of rTAAA. Our aim is to report the results of acute bEVAR in
patients with rTAAA.
Methods: A retrospective review of patients undergoing acute bEVAR
between 2008 and April 2015 in a single centre with large experience of the
elective procedures. Stent grafts used consisted mostly of off the shelf
endograft with 4 caudally oriented branches. Spinal drainage use was
decided depending on the emergency character of the operation. Values
are presented as median and range when not stated otherwise.
Results: 10 patients, (5 males, 64 (34e77) years old) underwent
bEVAR during the study period. TAAA had a median pre-operative
diameter of 70 (57- 90) mm and the anatomy according to Crawford was:
2 type I, 4 type II, 3 type III and 1 type IV. Median operative time was
436 (245e785) minutes. Endovascular conduit had to be used in 2 pa-
tients. Six patients had all 4 visceral arteries incorporated in the repair
while 2 and 1 patient had 3 and 2 arteries, respectively. One patient died
intra-operatively before the branches could be extended, making the
immediate technical success 90 % (n ¼ 9). Two more patients died within
30 days of bEVAR (30 day mortality of 30 %). Four of the nine patients
surviving bEVAR (44%) developed signs of post-operative spinal cord
ischemia. Three of the patients recovered completely while one devel-
oping the symptoms 4 days after bEVAR remained paraplegic. The 7
patients surviving more than 30 days were followed-up for 13 (1 e38)
months). During this period only one patient died of unrelated causes.
During the CT follow up (median of 13 (1e38) months) no aneurysms
expanded. One patient underwent an arch repair 9 months post-
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seal without endoleaks.
Conclusion: Acute bEVAR of ruptured TAAA provides good results in the
short-term suggesting it as a valid option in the acute setting.
Analysis of 100 Reported Deaths after Elective TEVAR/EVAR in 1
Year Reveals At Least Half were Preventable!
R. Gambhir, H. Slim, H. Mistry, A. Choong, D. Valenti, H. Rashid
King’s College Hospital, London, United Kingdom
Introduction:
Objective: To analyse the cause of deaths following elective TEVAR and
EVAR as reported on manufactures and user facility device experience
(MAUDE) database of US FDA and identify areas of concern.
Methods: The MUADE database was searched for deaths associated
with the use of Aortic stent grafts. The search criteria used was ‘System,
Endovascular Graft, and Aortic Aneurysm’. Search was done retrospectively
from 31 Jan 2015 for 100 consecutive death reports.
Results: Six different Aortic stent graft systems had been used. There
was no report of device related death, all were procedure related with non
IFU use in over 20% of cases. 30% deaths occurred in peri-operative period
from causes like hypovolemia from aortic or iliac rupture, retrograde or
antegrade dissections, air embolism. Difﬁculty in deployment of stents or
accessories was reported in 15% and acute renal failure causing death in
25%. Open conversion was associated with death in over 90% of patients.
Delayed rupture with or without sac expansion was noted in 20% of pa-
tients. No cause of death was identiﬁed in 10% of patients.
Conclusion:Deaths after elective TEVAR/EVAR are a reality that cannot be
ignored. There is a need to take ownership of the reporting systems by
physicians. Better sharing of adverse events may help prevent some of these
deaths.
Intra-operative Analysis of Motor Evoked Potentials to Evaluate
the Risk of Paraplegia during Branched EVAR for Thoraco-
abdominal Aneurysm
P.M. Kasprzak, M. Wagenschwanz, B. Cucuruz, W. Mess, R. Kopp
Department of Vascular and Endovascular Surgery, University Hospital
Regensburg, Germany
Introduction: Spinal cord ischemia (SCI) is a major complication after aortic
repair of thoraco-abdominal aneurysms (TAAA). Recently, we introduced
the concept of temporary aneurysm sack perfusion (TASP) to prevent
paraplegia during branched EVAR for TAAA. These patients seem to have a
reduced risk for post-operative SCI, but they need a second procedure for
branch occlusion. Intra-operative assessment of the neurologic status using
motor evoked potentials (MEPs) might allow an intra-operative decision for
TASP and early or late side branch completion.
Methods: From 07/2007e01/2015, 105 patients with TAAA were
treated with branched standard or custom made endovascular stent grafts.
All patients received peri-operative spinal drainage. Temporary aneurysm
sack perfusion (TASP) was performed for SCI prevention in n ¼ 52 patients.
Intra-operative assessment of spinal cord function using MEPs was per-
formed in n ¼ 27 (26%) patients. In n ¼ 20 (19%) patients additional intra-
operative balloon occlusion of the TASP branch was performed. De-
mographic data, comorbidities, neurologic symptoms and variables related
to aneurysm or endovascular treatment were analyzed. Post-operative SCI
was deﬁned as motor deﬁciency (Tarlov 0e2) day 0e7 post-operatively and
day 30.
Results: Post-operative transitory neurologic deﬁciency was
observed in 21/105 (20%) patients and 13/105 (12%) patients had
paraplegia after 30 days. In the TASP group 3/52 (5.7 %) patients had
severe SCI after bEVAR, two of them after secondary branch occlusion.
None of these 2 patients had intra-operative MEPs monitoring. Based
on intra-operative MEPs monitoring with an additional side branch
balloon occlusion test for 45 min 7/20 patients with low risk of spinal
cord ischemia had intra-operative immediate side branch occlusion and
no paraplegia. In 13/20 patients a decrease of motor evoked potentialswas observed and these patients had TASP with secondary side branch
occlusion.
Conclusion: Neurologic monitoring during bEVAR with MEPs is feasible
and with relevant information regarding the risk of paraplegia and the
therapeutic concept including TASP.
Deﬁnite Plaque Echolucency is Associated with a Higher Risk of
Ipsilateral Ischaemic Stroke during Early Follow up in the
Asymptomatic Carotid Surgery Trial-1 (ACST-1)
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Introduction: Several carotid plaque characteristics, including a thin ﬁbrous
cap, lipid necrotic core and intraplaque haemorrhage, have been suggested
as potential markers to select patients at high risk for future stroke. On
ultrasound, these “high risk” characteristics appear echolucent. The
Asymptomatic Carotid Surgery Trial-1 (ACST-1) is the largest randomised
controlled trial comparing carotid endarterectomy (CEA) with deferral of
CEA in patients with severe asymptomatic carotid artery stenosis. We
aimed to assess whether ultrasound characterized plaque echogenicity was
a predictor for ischaemic stroke in asymptomatic patients randomized to
deferred treatment in ACST-1.
Methods: 814 patients randomized to deferred surgery who had
baseline plaque assessment conﬁdentially classiﬁed as echolucent (>25%
soft plaque) or non-echolucent (<25% soft plaque) were studied. Kaplan-
Meier survival curves were used to calculate cumulative rates of ipsilateral
ischaemic stroke in both groups.
Results: Life table analysis showed a signiﬁcantly higher 5 year risk of
ipsilateral stroke in patients with deﬁnite echolucent plaques (8.0%; 95% CI:
6.4 - 9.6) when compared to patients with deﬁnitely non-echolucent plaques
(3.1%; 2.1 - 4.1) (p ¼ 0.009). After adjustments of other risk factors, plaque
echolucency was associated with a 2.5 times increased risk of ipsilateral
ischaemic stroke (HR 2.52, 95% CI: 1.20e5.25; p ¼ 0.014). The use of lipid
lowering therapy was low in both groups during the ﬁrst 5 years after
randomization but rose signiﬁcantly thereafter and during the later stages of
follow up, and was more commonly prescribed in patients with echolucent
plaques (p ¼ 0.001). The risk of ipsilateral ischaemic stroke at 10 years was
similar for both levels of echogenicity (p ¼ 0.421) as was the risk of any
stroke at 10 years (p ¼ 0.632).
Conclusion: Deﬁnite plaque echolucency (>25% soft plaque) might be a
predictor of ipsilateral stroke and is associated with a higher 5 year ipsi-
lateral stroke risk in these trial patients with asymptomatic carotid disease.
The similar stroke risk outcomes at 10 years for both groups could possibly
be explained by a higher use of lipid lowering therapy during later follow
up in patients with deﬁnite echolucent plaques.
Validation of a Risk Scoring System to Predict Life Expectancy
after CEA in Patient with Asymptomatic Carotid Artery Stenosis
I. Barbetta, D. Bissacco, M. Carmo, S. Bonardelli, S. Trimarchi,
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Introduction: Recent guidelines regarding surgical treatment of asymp-
tomatic carotid stenosis recommend exclusion of patients without a min-
imum life-expectancy of 3 e5 years. Purpose of this study is to validate a
previously derived risk scoring system to identify factors associated with a
higher mortality during long-term follow up after carotid endarterectomy
(CEA).
Methods: The factors were derived from a cohort of 648 asymptomatic
patients. According to the weight of each variable, the score system
included age (<70 ¼ 0 points, 70e79 ¼ 4 points, 80 ¼ 8 points), renal
status (creatinine 1.5 ¼ 4 points and dialysis ¼ 8 points), chronic
